| Mar 4, 2026 |
Mar 6, 2026 |
SAMAD SAM
|
CFO |
Sell |
100.0
|
+6,227
|
23.03%
|
✗
|
$1.6M |
| Mar 4, 2026 |
Mar 6, 2026 |
Doherty Catherine T.
|
EVP, Regional Businesses |
Sell |
52.5
|
-
|
0.00%
|
✓
|
$2.3M |
| Mar 4, 2026 |
Mar 6, 2026 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
97.5
|
+3,356
|
39.45%
|
✗
|
$476.5K |
| Mar 4, 2026 |
Mar 6, 2026 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
52.5
|
-
|
0.00%
|
✓
|
$1.5M |
| Mar 4, 2026 |
Mar 6, 2026 |
Davis J. E.
|
CEO |
Sell |
100.0
|
+25,238
|
21.54%
|
✗
|
$5.4M |
| Mar 4, 2026 |
Mar 6, 2026 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
52.5
|
-
|
0.00%
|
✓
|
$1.2M |
| Mar 4, 2026 |
Mar 6, 2026 |
Deppe Michael J
|
SVP, Corp. Controller & CAO |
Sell |
82.5
|
+723
|
2.10%
|
✗
|
$153.6K |
| Mar 4, 2026 |
Mar 6, 2026 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
97.5
|
+3,572
|
30.05%
|
✗
|
$538.4K |
| Mar 2, 2026 |
Mar 4, 2026 |
Doherty Catherine T.
|
EVP, Regional Businesses |
Sell |
45.0
|
-1,280
|
-1.76%
|
✓
|
$264K |
| Mar 2, 2026 |
Mar 4, 2026 |
SAMAD SAM
|
CFO |
Sell |
22.5
|
-869
|
-3.11%
|
✗
|
$178K |
| Mar 2, 2026 |
Mar 4, 2026 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
46.3
|
-814
|
-1.85%
|
✓
|
$168.3K |
| Mar 2, 2026 |
Mar 4, 2026 |
Davis J. E.
|
CEO |
Sell |
27.5
|
-12,968
|
-9.96%
|
✓
|
$2.7M |
| Mar 2, 2026 |
Mar 4, 2026 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
38.8
|
-640
|
-4.04%
|
✓
|
$132.3K |
| Mar 2, 2026 |
Mar 4, 2026 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
26.3
|
-205
|
-1.70%
|
✗
|
$42K |
| Mar 2, 2026 |
Mar 4, 2026 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
26.3
|
-188
|
-2.16%
|
✗
|
$38.5K |
| Mar 2, 2026 |
Mar 4, 2026 |
Deppe Michael J
|
SVP, Corp. Controller & CAO |
Sell |
43.8
|
-88
|
-0.25%
|
✗
|
$18K |
| Feb 18, 2026 |
Feb 20, 2026 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
90.0
|
+457
|
2.97%
|
✓
|
$308.1K |
| Feb 18, 2026 |
Feb 20, 2026 |
SAMAD SAM
|
CFO |
Sell |
85.0
|
+2,169
|
1.93%
|
✗
|
$388.6K |
| Feb 18, 2026 |
Feb 20, 2026 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
75.0
|
+254
|
0.58%
|
✓
|
$362.6K |
| Feb 18, 2026 |
Feb 20, 2026 |
Davis J. E.
|
CEO |
Sell |
95.0
|
+9,673
|
8.03%
|
✗
|
$1.3M |
| Feb 18, 2026 |
Feb 20, 2026 |
Doherty Catherine T.
|
EVP, Regional Businesses |
Sell |
67.5
|
+334
|
0.46%
|
✓
|
$535.1K |
| Feb 18, 2026 |
Feb 20, 2026 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
87.5
|
+1,640
|
4.48%
|
✗
|
$103.6K |
| Feb 18, 2026 |
Feb 20, 2026 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
87.5
|
+1,166
|
3.41%
|
✗
|
$87.9K |
| Feb 18, 2026 |
Feb 20, 2026 |
Deppe Michael J
|
SVP, Corp. Controller & CAO |
Sell |
68.8
|
+184
|
0.52%
|
✗
|
$37.9K |
| Jan 28, 2026 |
Feb 20, 2026 |
Lassiter Wright III
|
Director |
Buy |
55.0
|
+7
|
0.08%
|
✗
|
$1.3K |
| Jan 28, 2026 |
Feb 20, 2026 |
CARTER ROBERT B
|
Director |
Buy |
60.0
|
+6
|
0.22%
|
✗
|
$1.1K |
| Jan 28, 2026 |
Feb 20, 2026 |
Gregg Vicky B
|
Director |
Buy |
61.3
|
+67
|
0.39%
|
✗
|
$12.3K |
| Feb 13, 2026 |
Feb 17, 2026 |
Doherty Catherine T.
|
EVP, Regional Businesses |
Sell |
8.1
|
-26,165
|
-26.50%
|
✓
|
$5.4M |
| Jan 28, 2026 |
Feb 12, 2026 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
18.8
|
-5,614
|
-15.43%
|
✓
|
$1.2M |
| Nov 25, 2025 |
Nov 28, 2025 |
Davis J. E.
|
CEO |
Sell |
2.5
|
-55,093
|
-31.38%
|
✓
|
$10.6M |
| Nov 25, 2025 |
Nov 28, 2025 |
Gregg Vicky B
|
Director |
Sell |
22.5
|
-1,250
|
-6.84%
|
✗
|
$239.7K |
| Nov 18, 2025 |
Nov 20, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
5.0
|
-7,946
|
-51.34%
|
✓
|
$1.5M |
| Nov 5, 2025 |
Nov 7, 2025 |
Davis J. E.
|
CEO |
Sell |
37.5
|
-7,143
|
-5.60%
|
✗
|
$1.3M |
| Oct 21, 2025 |
Oct 24, 2025 |
SAMAD SAM
|
CFO |
Neutral |
60.0
|
+68
|
0.26%
|
✗
|
- |
| Oct 21, 2025 |
Oct 24, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Neutral |
60.0
|
+46
|
0.30%
|
✗
|
- |
| Oct 21, 2025 |
Oct 24, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Neutral |
55.0
|
+15
|
0.14%
|
✗
|
- |
| Oct 22, 2025 |
Oct 24, 2025 |
PFEIFFER GARY M
|
Director |
Sell |
20.0
|
-1,482
|
-4.79%
|
✗
|
$270.3K |
| Oct 21, 2025 |
Oct 24, 2025 |
Gregg Vicky B
|
Director |
Neutral |
60.0
|
+70
|
0.38%
|
✗
|
- |
| Oct 21, 2025 |
Oct 24, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Neutral |
55.0
|
+15
|
0.20%
|
✗
|
- |
| Oct 21, 2025 |
Oct 24, 2025 |
CARTER ROBERT B
|
Director |
Neutral |
60.0
|
+6
|
0.22%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
RING TIMOTHY M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Oct 1, 2025 |
Oct 3, 2025 |
Lassiter Wright III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Sep 26, 2025 |
Sep 30, 2025 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
51.3
|
-227
|
-0.52%
|
✓
|
$42.7K |
| Sep 23, 2025 |
Sep 25, 2025 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
3.8
|
-28,463
|
-25.78%
|
✓
|
$5.3M |
| Aug 21, 2025 |
Aug 25, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
22.5
|
-1,975
|
-11.45%
|
✓
|
$365.4K |
| Aug 19, 2025 |
Aug 21, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
12.5
|
-4,532
|
-20.81%
|
✓
|
$829.4K |
| Aug 15, 2025 |
Aug 19, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
22.5
|
-1,975
|
-10.28%
|
✓
|
$355.5K |
| Aug 13, 2025 |
Aug 15, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
46.3
|
-123
|
-1.18%
|
✗
|
$21.6K |
| Aug 6, 2025 |
Aug 8, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
22.5
|
-5,535
|
-12.05%
|
✓
|
$968.6K |
| Jul 30, 2025 |
Aug 1, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
10.0
|
-10,479
|
-24.81%
|
✓
|
$1.8M |
| Jul 21, 2025 |
Jul 25, 2025 |
SAMAD SAM
|
CFO |
Buy |
61.3
|
+72
|
0.28%
|
✗
|
$12.1K |
| Jul 21, 2025 |
Jul 25, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Buy |
61.3
|
+80
|
0.38%
|
✗
|
$13.4K |
| Jul 21, 2025 |
Jul 25, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Buy |
60.0
|
+27
|
0.21%
|
✗
|
$4.5K |
| Jul 21, 2025 |
Jul 25, 2025 |
Lassiter Wright III
|
Director |
Buy |
55.0
|
+7
|
0.08%
|
✗
|
$1.2K |
| Jul 21, 2025 |
Jul 25, 2025 |
Gregg Vicky B
|
Director |
Buy |
61.3
|
+79
|
0.44%
|
✗
|
$13.2K |
| Jul 21, 2025 |
Jul 25, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Buy |
60.0
|
+17
|
0.23%
|
✗
|
$2.8K |
| Jul 21, 2025 |
Jul 25, 2025 |
CARTER ROBERT B
|
Director |
Buy |
60.0
|
+7
|
0.26%
|
✗
|
$1.2K |
| Jul 16, 2025 |
Jul 17, 2025 |
SAMAD SAM
|
CFO |
Sell |
22.5
|
-850
|
-3.21%
|
✗
|
$143.7K |
| Jul 1, 2025 |
Jul 2, 2025 |
RING TIMOTHY M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Jul 1, 2025 |
Jul 2, 2025 |
Lassiter Wright III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
CARTER ROBERT B
|
Director |
Neutral |
90.0
|
+1,203
|
81.17%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
Diaz Luis
|
Director |
Neutral |
90.0
|
+1,203
|
42.20%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
Gregg Vicky B
|
Director |
Neutral |
85.0
|
+1,203
|
7.10%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
Doi Tracey
|
Director |
Neutral |
90.0
|
+1,203
|
22.75%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
MAIN TIMOTHY L
|
Director |
Neutral |
82.5
|
+1,203
|
4.79%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
MORRISON DENISE M
|
Director |
Neutral |
90.0
|
+1,203
|
12.61%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
Lassiter Wright III
|
Director |
Neutral |
90.0
|
+1,203
|
15.36%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
RING TIMOTHY M
|
Director |
Neutral |
82.5
|
+1,203
|
4.25%
|
✗
|
- |
| May 15, 2025 |
May 19, 2025 |
PFEIFFER GARY M
|
Director |
Neutral |
82.5
|
+1,203
|
4.08%
|
✗
|
- |
| May 12, 2025 |
May 14, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
17.5
|
-1,748
|
-18.91%
|
✓
|
$306.8K |
| Apr 21, 2025 |
May 2, 2025 |
SAMAD SAM
|
CFO |
Buy |
61.3
|
+74
|
0.28%
|
✗
|
$12.2K |
| Apr 21, 2025 |
May 2, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Buy |
60.0
|
+27
|
0.21%
|
✗
|
$4.4K |
| Apr 21, 2025 |
May 2, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Buy |
61.3
|
+81
|
0.39%
|
✗
|
$13.3K |
| Apr 21, 2025 |
May 2, 2025 |
Gregg Vicky B
|
Director |
Neutral |
60.0
|
+68
|
0.40%
|
✗
|
- |
| Apr 21, 2025 |
May 2, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Buy |
60.0
|
+25
|
0.27%
|
✗
|
$4.1K |
| Apr 2, 2025 |
Apr 4, 2025 |
Davis J. E.
|
CEO |
Sell |
8.8
|
-39,191
|
-23.49%
|
✓
|
$6.6M |
| Apr 2, 2025 |
Apr 4, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
17.5
|
-2,555
|
-16.92%
|
✓
|
$434.4K |
| Apr 1, 2025 |
Apr 3, 2025 |
Lassiter Wright III
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Apr 1, 2025 |
Apr 3, 2025 |
RING TIMOTHY M
|
Director |
Neutral |
52.5
|
-
|
0.00%
|
✗
|
- |
| Mar 26, 2025 |
Mar 28, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
48.8
|
-162
|
-0.77%
|
✗
|
$27K |
| Mar 26, 2025 |
Mar 28, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
46.3
|
-256
|
-2.70%
|
✗
|
$42.7K |
| Mar 17, 2025 |
Mar 19, 2025 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
26.3
|
-4,643
|
-9.59%
|
✓
|
$789.3K |
| Mar 5, 2025 |
Mar 7, 2025 |
Doherty Catherine T.
|
EVP, Regional Businesses |
Sell |
30.0
|
-5,370
|
-6.90%
|
✓
|
$935.1K |
| Mar 3, 2025 |
Mar 5, 2025 |
DEPPE MICHAEL J
|
SVP, Corp. Controller & CAO |
Sell |
40.0
|
-848
|
-2.36%
|
✗
|
$444.6K |
| Mar 3, 2025 |
Mar 5, 2025 |
Doherty Catherine T.
|
EVP, Regional Businesses |
Sell |
95.0
|
+4,260
|
5.79%
|
✓
|
$1.1M |
| Mar 3, 2025 |
Mar 5, 2025 |
Davis J. E.
|
CEO |
Sell |
100.0
|
+28,599
|
20.69%
|
✗
|
$5.8M |
| Mar 3, 2025 |
Mar 5, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
97.5
|
+1,563
|
11.57%
|
✗
|
$498.8K |
| Mar 3, 2025 |
Mar 5, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
97.5
|
+3,288
|
18.41%
|
✗
|
$414.5K |
| Mar 3, 2025 |
Mar 5, 2025 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
92.5
|
+3,729
|
8.35%
|
✓
|
$838.6K |
| Mar 4, 2025 |
Mar 5, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
97.5
|
+3,494
|
58.40%
|
✗
|
$316.7K |
| Mar 4, 2025 |
Mar 5, 2025 |
SAMAD SAM
|
CFO |
Sell |
100.0
|
+6,200
|
30.73%
|
✗
|
$1.3M |
| Feb 26, 2025 |
Feb 28, 2025 |
SAMAD SAM
|
CFO |
Sell |
42.5
|
-869
|
-4.13%
|
✗
|
$149.3K |
| Feb 26, 2025 |
Feb 28, 2025 |
Davis J. E.
|
CEO |
Sell |
40.0
|
-2,966
|
-2.10%
|
✗
|
$509.4K |
| Feb 26, 2025 |
Feb 28, 2025 |
PREVOZNIK MICHAEL E
|
SVP & General Counsel |
Sell |
45.0
|
-814
|
-1.79%
|
✓
|
$140.3K |
| Feb 26, 2025 |
Feb 28, 2025 |
Plewman Patrick
|
SVP for Diagnostic Services |
Sell |
46.3
|
-229
|
-1.27%
|
✗
|
$39.3K |
| Feb 26, 2025 |
Feb 28, 2025 |
KUPPUSAMY KARTHIK
|
SVP, Clinical Solutions |
Sell |
46.3
|
-233
|
-1.70%
|
✗
|
$40K |
| Feb 26, 2025 |
Feb 28, 2025 |
Doherty Catherine T.
|
EVP, Regional Businesses |
Sell |
45.0
|
-1,279
|
-1.71%
|
✓
|
$220.4K |
| Feb 26, 2025 |
Feb 28, 2025 |
DEPPE MICHAEL J
|
SVP, Corp. Controller & CAO |
Sell |
51.3
|
-88
|
-0.24%
|
✗
|
$15.1K |
| Feb 26, 2025 |
Feb 28, 2025 |
DELANEY MARK E
|
SVP & Chief Commercial Officer |
Sell |
46.3
|
-214
|
-3.45%
|
✗
|
$36.8K |
| Feb 19, 2025 |
Feb 21, 2025 |
SAMAD SAM
|
CFO |
Sell |
42.5
|
-1,031
|
-4.67%
|
✗
|
$175K |